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Effective treatments for degenerative and traumatic diseases of the nervous system are not
currently available. The support or replacement of injured neurons with neural grafts, already
an established approach in experimental therapeutics, has been recently invigorated with the
addition of neural and embryonic stem-derived precursors as inexhaustible, self-propagating
alternatives to fetal tissues. The adult spinal cord, i.e., the site of common devastating injuries
and motor neuron disease, has been an especially challenging target for stem cell therapies. In
most cases, neural stem cell (NSC) transplants have shown either poor differentiation or a




of these cells into neurons that formed axons and synapses and established extensive contacts
with host motor neurons. Spinal cord microenvironment appeared to influence fate choice, with
centrally located cells taking on a predominant neuronal path, and cells located under the pia
membrane persisting as NSCs or presenting with astrocytic phenotypes. Slightly fewer than one-
tenth of grafted neurons differentiated into oligodendrocytes. The presence of lesions increased
the frequency of astrocytic phenotypes in the white matter.
Conclusions
NSC grafts can show substantial neuronal differentiation in the normal and injured adult
spinal cord with good potential of integration into host neural circuits. In view of recent similar
findings from other laboratories, the extent of neuronal differentiation observed here disputes
the notion of a spinal cord that is constitutively unfavorable to neuronal repair. Restoration of
spinal cord circuitry in traumatic and degenerative diseases may be more realistic than
previously thought, although major challenges remain, especially with respect to the
establishment of neuromuscular connections.
The Editors’ Summary of this article follows the references.
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Degenerative and traumatic diseases of the nervous system
are characterized by loss of neurons and their connections.
Effective treatments for these conditions are presently
unavailable. In the ﬁeld of experimental therapeutics two
major approaches have been taken: prevention of cell death
with compounds that interfere with decision-making steps in
cell death pathways and the replacement or support of
degenerating neurons with neural grafts [1,2]. Neural stem
cells (NSCs) are a promising alternative to fetal tissues for cell
therapies, primarily due to their self-renewal and pluripo-
tentiality [3,4]. The use of human-derived NSCs has the
additional advantage of yielding translational information
that is relevant to clinical therapeutics.
The adult spinal cord represents an especially challenging
environment for the survival and differentiation of NSCs
because of the apparent lack of cells and/or signals promoting
regeneration [5]. For the most part, NSC grafts into the adult
injured cord have shown either poor differentiation [6,7] or a
restricted differentiation into the glial lineage [8,9], the latter
attributable to the relative preference of pluripotent pre-
cursors for non-neuronal fates. However, a few studies using
embryonic stem cell-/embryonic body-derived NSCs [10] or
lineage-restricted neuronal progenitors [11,12] have achieved
good neuronal differentiation of grafted cells, thus mounting
a challenge to the notion of the spinal cord as an environ-
ment unfavorable to neuronal differentiation. In the present
report, we grafted NSCs derived from human embryonic cord
and grown in monolayer into the spinal cord of normal or
injured adult rats and explored the differentiation fate and
degree of structural integration of these cells as a function of
time, anatomical location, and presence or absence of injury.
Methods
Derivation of Human NSCs
Human NSCs were prepared from the cervical and upper
thoracic spinal cord of a single eight-week human fetus after
an elective abortion. The tissue was donated by the mother in
a manner fully compliant with the guidelines of the National
Institutes of Health (NIH) and the Food and Drug Admin-
istration (FDA) and approved by an outside independent
review board. Spinal cord tissue was cleared of meninges and
dorsal root ganglia and dissociated into a single-cell
suspension by mechanical trituration in serum-free, modiﬁed
N2 medium composed of 100 mg/l human plasma apo-
transferrin, 25 mg/l recombinant human insulin, 1.56 g/l
glucose, 20 nM progesterone, 100 lM putrescine, and 30 nM
sodium selenite in DMEM/F12, to which basic ﬁbroblast
growth factor (bFGF) (10 ng/ml) was added. The initial culture
was serially expanded as monolayers in precoated ﬂasks or
plates as described [13]. Approximately 6.1 3 10
6 cells were
obtained upon the initial dissociation of the spinal cord
tissue. All cells were plated onto one 150-mm plate in 20 ml of
growth media. Growth medium was changed every other day
and, on alternate days, 10 ng/ml of bFGF was added.
The ﬁrst passage was conducted at 16 d postplating. At this
time point, the culture was composed mostly of dividing NSCs
and postmitotic neurons. Dividing cells were harvested by
brief treatment with trypsin (0.05% þ 0.53 mM EDTA)
followed by mechanical dissociation. A single-cell suspension
was thus derived that was centrifuged at 1,400 rpm for ﬁve
minutes. The cell pellet was resuspended in the growth
medium, and cells were replated in new precoated plates at
1.2310
6 cellsin 20 mlof medium per150 mm plate. Cells were
harvested at approximately 75% conﬂuence, which occurred
within ﬁve or six days. This process was repeated for 20
passages.Cellsfromvariouspassageswerefrozeninthegrowth
medium plus 10% DMSO and stored in liquid nitrogen. Upon
thawing, overall rate of recovery was 80%–95%. The resulting
cell line, produced by epigenetic means only and by using
bFGF as the sole mitogen, was coded ‘‘566RSC.’’
Passage 10–12 cells were used in this study. One cryopre-
served vial of the appropriate passage was thawed, washed,
and cultured again as described above, 5–7 d prior to surgery.
For multiple days of surgeries, cultures were seeded at varying
densities, so that each ﬂask reached conﬂuence on the
designated day of surgery. Cells were subsequently harvested
by brief enzymatic treatment as described above, washed in a
buffered saline solution, couriered to the surgery site on wet
ice, and used within 24 h. Viability of cells on ice was typically
greater than 80% within this 24-h period.
Experimental Subjects and Surgical Procedures
Nude rats (160–180 g, strain CR: NIH-RNU, n ¼ 37) were
purchased from the animal service of the National Cancer
Institute and were the main experimental subjects of this
study. These animals were subjected to surgical interventions
2 wk prior to NSC grafting; interventions included proximal
ventral rhizotomies (n ¼ 18) [14], excitotoxic lesions (n ¼ 12)
[15], or sham surgeries (n¼6). An additional small number of
commonly used Sprague-Dawley rats (n ¼ 3, Charles River
Laboratories [http://www.criver.com]) was used for the pur-
pose of proving the concept that the results reported here
were unrelated to the athymic state of our experimental
animals. These animals were used for transplantation without
prior lesions and were immunosuppressed with daily in-
jections of FK506 (2 lg/g i.p., Prograf, Fujisawa Healthcare
[http://www.astellas.com/]). Surgeries were performed using
gas anesthesia (enﬂurane:oxygen:nitrous oxide ¼ 1:33:66) and
aseptic methods. Animal surveillance and the surgical
procedures described here were carried out according to
protocols approved by the Animal Care and Use Committee
of the Johns Hopkins Medical Institutions.
Rhizotomies involved transections of L4 and L5 roots with
extraspinal avulsion of the corresponding spinal nerves as
described [14]. In brief, the left L4 and L5 spinal nerve roots
were exposed at the level of the iliac crest after splitting the
sacroiliac joint, and roots were avulsed by applying a steady
moderate traction with forceps. Excitotoxic lesions were
made with 100 ll of 150 mM of the kainate analog L-
homocysteic acid (HCA) [15] absorbed into a gelfoam pledget
that was laid on the dorsal pia of L4–L5 for a period of 20 min
after a dorsal laminectomy. This strategy optimizes the need
to lesion a rather extensive group of vulnerable (motor)
neurons throughout L4–L5 without causing epileptogenesis.
The sham group was subjected to dorsal laminectomy and
subsequent wound closure. The parallel use of a severe,
proximal axotomy lesion and a mild neurotoxic injury
allowed for some experimental variance in the method and
degree of motor neuron injury; the neurotoxic paradigm
offers the additional advantage of preserving the conduit for
the assessment of de novo axonal elongation toward the
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disruption of the blood-brain barrier and, therefore, consid-
erably reduce the likelihood of glial scarring.
Animals were subjected to dorsal laminectomy at the lower
thoracic level and received four injections of 10
5 NSCs each
in 0.5 ll suspension into ventral L4 and L5 on the left side 2
wk after lesion. Injections were made stereotaxically on a
Kopf spinal unit 1 mm lateral to the midline using pulled-
beveled glass micropipettes connected, via silastic tubing, to
10 ll Hamilton microsyringes. Animals were allowed to
survive for 3 wk, 3 mo, or 6 mo (avulsion lesions), 3 or 6 mo
(excitotoxic lesions), or 6 mo (sham lesions) (n ¼ 6 for each
treatment 3 time point).
Histology, Immunocytochemistry, and Microscopy
The survival and phenotypic fate of NSCs were assessed with
immunocytochemistry (ICC), including ABC-peroxidase ICC
and dual-label immunoﬂuorescence. Tissues were prepared
from animals perfused with 4% freshly depolymerized,
neutral-buffered paraformaldehyde. The thoracolumbar spi-
nal cord segments with attached roots and lumbar nerves were
further ﬁxed by immersion in the same ﬁxative for an
additional 4 h after removal of the dura. Blocks containing
theentiregraftedareaplus1mmborderaboveandbelowwere
subdissected, equilibrated in 30% neutral-buffered sucrose,
and frozen for further processing. L3–S1 roots were processed
separately as whole-mount preparations or after teasing the
rootletswithheat-coagulatedtipsofglasspipettes.Blockswere
sectioned transversely (30 lm) on a freezing microtome;
sections were kept in an antifreeze solution until processed
forNSCsurvivalorphenotypicstudies.Survivalstudiesutilized
human nuclear antigen (HNu) immunoperoxidase-stained
sections (; 15 per animal, i.e. every 24th section through the
L3–S1block) with random sampling of the ﬁrstsection. HNu is
a selective nuclear marker of cells of human origin [16]. NSC
differentiationutilizedfourtoﬁvesections1.5mmaparttaken
throughthegraftingareaandstainedwithdual-labelimmuno-
ﬂuorescence; in most cases, dual-label immunoﬂuorescence
combined HNu with another cellular marker.
After permeabilization with 0.1% Triton X-100 and non-
speciﬁc site blocking with 5% normal serum, slide-mounted
sections were incubated in primary antibodies in 1 mg/ml
BSA with 0.1% Triton X-100 (4 8C, overnight). Primary
antibodies were used to address human (graft) versus rat
(host) cell identity, mitotic activity, and neuronal, astrocytic,
and oligodendrocytic phenotype speciﬁcation and included a
number of monoclonal antibodies and antisera as laid out in
Table 1. Normal immunoglobulin G (IgG) from the species of
origin of the primary antibodies served as negative controls.
Peroxidase-based detection of HNu immunoreactivity uti-
lized an enhanced version of the avidin-biotin method (ABC-
elite kit; Vector [http://www.vectorlabs.com/]) and a standard
DAB chromagen reaction. Dual immunoﬂuorescence utilized
an indirect protocol combining goat/donkey anti-mouse IgG
and goat/donkey anti-rabbit IgG labeled with Cy3 or Cy2 in a
corresponding fashion (1:200; Jackson ImmunoResearch
[http://www.jacksonimmuno.com/]); anti-rabbit IgGs were
used against the species of origin of the phenotype-marking
antibody. Sections were incubated in these antibodies for 2–4
h at RT and were then counterstained with the ﬂuorescent
DNA dye DAPI. Sections were mounted with DPX and
studied with epiﬂuorescence or confocal microscopy. Triple
immunoﬂuorescence was used for the colocalization of HNu,
Bsn (Bassoon), and TUJ1. This procedure involved ﬁrst a dual
(indirect) immunoﬂuorescent step, in which Cy5 replaced
Cy3 as ﬂuorophore for the goat anti-mouse IgG, and then a
direct immunoﬂuorescent step, in which sections were
incubated in HNu antibody coupled to the red ﬂuorophore
Alexa 594 (Molecular Probes [http://probes.invitrogen.com/]).
Cell Counts for Surviving and Differentiating NSCs
ToassessNSCgraftsurvival,wecountednumbersofHNu(þ)
proﬁles through L4–L5 using stereological assumptions based
on the optical fractionator concept [17]. We used serial
immunoperoxidase-stained sections that were sampled in a
Table 1. Primary Antibodies
Target Phenotypes Target Proteins/Epitopes Host Dilution Vendor
Human identity Human nuclear protein antibody (HNu) Mouse 1:800 Chemicon (http://www.chemicon.com/)
Mitotic marker Ki67 antigen (NCL-Ki67p) Rabbit 1:1,000 Novocastra Labs (http://www.vision-bio.com/)
Neuron—migrating precursor Doublecortin (Dcx, C-18) Goat 1:400 Santa Cruz Biotech (http://www.scbt.com/)
Neuron—early Type III b-tubulin epitope J1 (TUJ1) Mouse 1:1,000 Covance (http://www.covance.com/)
Neuron—mature Neuronal nuclear epitope (NeuN) Mouse 1:1,000 Chemicon
Microtubule-associated protein 2 (MAP2) Mouse 1:1,000 Sigma (http://www.sigmaaldrich.com/)
Neuron—human-specific 70 kDa neurofilament (NF70) Mouse 1:100 Chemicon
Synaptophysin (Syn) Mouse 1:600 Chemicon
Neuron—rodent-specific Bassoon Mouse 1:400 Stressgen (http://www.stressgen.com/)
Neurotransmitter enzymes /
receptor / transporters
Glutamate decarboxylase 65,67 (GAD) Rabbit 1:400 Chemicon
Glutamate decarboxylase 67(GAD) Mouse 1:600 Chemicon
Choline acetyltransferase (ChAT) Goat 1:100 Chemicon
Vesicular glutamate transporter 1 (VGLUT1) Guinea pig 1:2,000 Chemicon
Vesicular glutamate transporter 2 (VGLUT2) Guinea pig 1:2,000 Chemicon
Glutamate receptor subunit 2 and 3 (GluR2/3) Rabbit 1:100 Chemicon
Common glial precursor A2B5 Mouse 1:200 Chemicon
Astrocyte Glial fibrillary acidic protein (GFAP) Rabbit 1:400 Dako (http://www.dako.com/)
Oligodendrocyte-mature Adenomatus polyposis coli (APC) Mouse 1:200 Calbiochem (http://www.calbiochem.com)
doi:10.1371/journal.pmed.0040039.t001
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afterprocessingwas18lm.Theoptical fractionatorprobewas
appliedwiththeaidofamotorized-stageAxioplanmicroscope
(Zeiss, www.zeiss.de) equipped with the Stereo Investigator V
hardware and software (MicroBrightField [http://www.
mbfbioscience.com/]). Contours of half spinal cords were
outlinedat53byablindedinvestigator,andcellswerecounted
using a 1003oil-immersion objective. A 40335 lm counting
framewasusedwithina300lm3300lmgridcoextensivewith
the outlined area. Counting depth (optical dissector height)
ranged 9–13 lm depending on average section thickness. A
guard volume of 1.0 lm was used to avoid sectioning-related
artifacts such as lost caps and uneven section surfaces.
To study NSC differentiation, we used a nonstereological
method of counting total number of HNu (þ) cells, as well as
cells dually labeled with HNu and a phenotypic marker on
randomly selected 1003ﬁelds through the ventral horn from
immunoﬂuorescent preparations. One ﬁeld in each one of
four sections, spaced 1 mm apart through the grafting area,
was used from each animal. Numbers of HNu (þ) and double-
labeled proﬁles were pooled from all four ﬁelds counted from
each case and grouped per experimental protocol. NSCs
located at or near the meninges were counted separately.
Percentages of double-labeled cells were generated per
parenchymal or meningeal sites at different time points for
each treatment group (n ¼ 4 animals per group). In the sham
group we only examined 6-mo data, and in the HCA group
data were available from the 3- and 6-mo, but not the 3-wk
group. On average, 2,040 and 1,970 cells were counted per
subject in parenchymal and meningeal sites, respectively. In
the 6-mo group, a more detailed anatomical analysis of
regional differentiation of grafted NSCs was performed. In
these cases, separate numbers were generated in the ventral
horn, dorsal horn, and ventral white matter, as outlined in the
Results section.
Variation in survival and differentiation, as function of
experimental protocol, graft location, and time point post-
surgery, was studied with one-way ANOVA followed by
Tukey’s multiple comparison post hoc test. Results are
expressed as mean 6 standard deviation.
Real-Time PCR Analysis of the Expression of Relevant
Trophic and Tropic Genes
RNA samples were extracted from 10
7 NSCs at various time
points of differentiation in vitro (0, 14, 29, and 42 d after
withdrawal of bFGF) using Trizol (Invitrogen [http://www.
invitrogen.com/]). Residual DNA was removed using the DNA-
free kit (Ambion [http://www.ambion.com/]). Template cDNA
was synthesized from 1 lg of RNA with the iScript cDNA
Synthesis kit (Bio-Rad http://www.bio-rad.com/]) and was
diluted 10-fold before PCR ampliﬁcation. SYBR green-based
real-time PCR was performed using the iCycler (Bio-Rad). 18s
rRNA was used as the reference transcript (e.g., control gene).
Table 2 lists the human-speciﬁc primers for bFGF [18], brain-
derived neurotrophic factor (BDNF) [19], vascular endothelial
growth factor (VEGF) [18], glial cell line-derived neurotrophic
factor [20], insulin-like growth factor-1 (IGF-1) [21], and
neuregulins (NRGs) 1, 2, 3 (NRG 1, 2, and 3) [22], all of which
were assayed because of a suspected or established role in
motor neuron development. PCR reactions, run in triplicate
for each sample, were carried out in 25 ll volume containing 2
llof1:10dilutionofcDNA,0.5llofeachsenseandantisense10
lM primer stocks, 12.5 ll iQ SYBR green Supermix (Bio-Rad),
and nuclease-free water. For either 18s rRNA or mRNA of
interest,exceptNRGtranscripts,cyclingconditionswere958C
for 5 min, followed by 40 cycles of 95 8C for 15 s and 60 8C for 1
min. For NRG 1, 2, and 3 the annealing temperature was 56 8C.
Reactions without template served as negative controls.
Melting curveanalysis was carried out by heatingthe amplicon
from 50 8Ct o9 58C in 90 0.5 8C increments. PCR efﬁciency
curves were made for each gene using ﬁve duplicate 5-fold
dilutions, corresponding to 0.08 to 50 ng of the initial total
RNA input into the RT reaction. Data were analyzed using the
Bio-Rad Gene Expression Macro version 1.1 for Microsoft
Excel. Normalized gene expression ratios were calculated as
described [23]. Brieﬂy, PCR efﬁciencies were calculated
Table 2. Primer Sequences Used for Real-Time PCR
Gene Family Gene Name Primer Sequence
Neurotrophic factor FGF-2 Sense 59-GTG TGC TAA CCG TAC CTG GC-39
Antisense 59-CTG GTG ATT TCC TTG ACC GG-39
BDNF Sense 59-CCA AGG CAG GTT CAA GAG G-39
Antisense 59- TCC AGC AGA AAG AGA AGA GGA-39
VEGF Sense 59-CCA TGG CAG AAG GAG GAG G-39
Antisense 59-ATT GGA TGG CAC TAG CTG CG-39
GDNF Sense 59-CTG ACT TGG GTC TGG GCT ATG-39
Antisense 59-TTG TCA CTC ACC AGC CTT CTA TTT-39
IGF-1 Sense 59-CAA CAA GCC CAC AGG GTA TGG-39
Antisense 59-GCA CTC CCT CTA CTT GCG TTC-39
Neuregulin NRG1 Sense 59-CTT GTA AAA TGT GCG GAG A-39
Antisense 59-GTC TTT CAC CAT GAA GCA CT-39
NRG2 Sense 59-GAG ACA GCC AAG TCC TAT TG-39
Antisense 59-CCC TCG ATG TAG TAG CAG AC-39
NRG3 Sense 59-AGG ACC TTG CAT ACT GTC TC-39
Antisense 59-ACT CCT TGG TAG CCT TCT TT-39
Standard 18s rRNA Sense 59-CGC CGC TAG AGG TGA AAT TC-39
Antisense 59-TTG GCA AAT GCT TTC GCT C-39
doi:10.1371/journal.pmed.0040039.t002
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[ 1/slope].Therelativeexpression
ratio of target genes was calculated using the equation: ratio¼
(Etarget)
D target Ct (control-sample)/(Eref)
D reference Ct (control-sample),
where the Ct is the point at which SYBR green ﬂuorescence
rises above background ﬂuorescence. Gene expression levels




In Vitro Differentiation and Trophic/Tropic Profile of
Human NSCs
NSCs prepared for grafting were propagated as a mono-
layer culture in the presence of bFGF and delivered to
animals within 24 h post-bFGF withdrawal. At that time, all
cells expressed the NSC marker nestin (Figure 1A), approx-
imately 5% were immunoreactive for the neuronal precur-
sor-speciﬁc marker PSA-NCAM, and less than 1% expressed
the neuronal markers TUJ1 and MAP2 or the astroglial
marker glial ﬁbrillary acidic protein (GFAP). With continued
culture in the absence of bFGF, about 50% of cells acquired
neuronal phenotypes as shown by MAP2 immunoreactivity
and cytological proﬁle (Figure 1B), and some differentiated
into GFAP (þ) astrocytic proﬁles (Figure 1C) within 2 wk. Very
few cells expressed oligodendrocyte/Schwann cell markers
within this time frame.
The expression of representative neurotrophic factors and
NRGs was studied by real-time PCR at 0, 14, 29, and 42 days
post-bFGF withdrawal, i.e. during the differentiation phase
(Figure 1D). Among neurotrophic factors, glial cell line-
derived neurotrophic factor and BDNF transcripts increased
3- and 7-fold respectively, whereas VEGF increased 15-fold by
day 29; signiﬁcant sustained increases were also noted for IGF-
1 (Figure 1D). Among NRGs, NRG1 and NRG3 transcripts,
particularly the latter, were also found to have signiﬁcantly
increased. The expression of all these factors declined after 4
wk, a pattern that may reﬂect some cellular deterioration that
is common in long-term culturing of mature neurons.
Survival and Migration of Human NSCs in Rat Spinal Cord
The examination of all stained sections from lesioned and
control animals shows a robust engraftment and excellent
long-term survival of NSCs in the adult spinal cord environ-
ment (Figure 2A and 2B). Stereological estimates of surviving
HNu (þ) cells show an average of 1.5 3 10
6 cells in the L4–L5
cord 6 mo postgrafting. This value represents a 3- to 4-fold
increase of the cell population present in the initial graft
(Figure 2C) and implies that the initial graft survived well and
underwent, on average, two mitotic divisions. This estimate is
consistent with a low frequency (3%–5%) of HNu (þ) cells
that also expressed the nuclear antigen Ki67 at 3 and 6 mo
postgrafting in all experimental conditions studied in this
paper (Figure 2F). Ki67 is a marker of all phases of cell cycle
Figure 1. In Vitro Differentiation of Human NSCs Used for Transplantation
(A) The vast majority of cells express the NSC-specific marker nestin (red) immediately before grafting. The DNA dye DAPI (blue) was used to reveal all
cells in culture.
(B and C) At 14 days within the differentiation phase (i.e., after bFGF removal), ; 50% of cells acquire MAP2 immunoreactivity and neuronal cytology,
with characteristic processes (red, B). A smaller number of cells differentiate into GFAP (þ) astrocytes (green, C).
(D) Real-time RT-PCR data showing increased neurotrophic factor and NRG expression in the course of NSC differentiation in vitro. The number of days
on top of the columns is the days NSCs have been in a phase of differentiation (after withdrawal of fibroblast growth factor). Results are expressed as
fold increases compared to levels expressed at the proliferation phase (day 0), the latter values designated as 1. Data represent average 6 standard
deviation of triplicate measurements of a representative cell culture sample at a given time point. The experiment was repeated twice with different
sets of cell samples and yielded very similar results.
Scale bars: 50 lm.
doi:10.1371/journal.pmed.0040039.g001
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Neural Stem Cell Grafts in Spinal CordFigure 2. Survival and Migration of Human NSCs in Rat Spinal Cord
Photomicrographs and graphs in (A–C) illustrate the localization and numbers of HNu (þ) cells at different time points postgrafting, whereas (D) and (E)
support the migratory phenotype of grafted HNu (þ) cells, and (F) confirms their low mitotic activity.
(A and B) At 3 mo postgrafting most HNu (þ) cells, indicated as red profiles with an arrow in (A), are located around the injection sites and along needle
tracks. By six months (B), HNu (þ) cells show widespread migration away from the injection site in both the gray and white matter, and many are seen in
the white matter and a few in the gray matter of the contralateral side. (B) is a composite of several fields to show the extent of migration. Arrow in (B)
shows the colonization, by NSC-derived cells, of the central nervous system portion of the dorsal root (note the central nervous system–peripheral
nervous system transition zone).
(C) Bar graphs showing HNu (þ) cell numbers at the time of grafting (0) and at three weeks (3w), three months (3m), and six months (6m) postgrafting in
the different treatment groups (avulsion, red; HCA treatment, blue; sham, green). Far left graph shows numbers of HNu (þ) cells ipsilateral to the
grafting site (Ipsi), and far right graph shows numbers on the contralateral gray matter (Contra). Brackets show the results of post hoc testing when
ANOVA was significant in the avulsion and HCA groups ipsilateral to grafting; in all other cases, significance was established with a Student’s t-test.
Asterisk indicates statistical significance at p   0.05. Method of section selection is illustrated on the extreme left.
(D) Dcx, a marker for migrating neuronal precursors, was expressed by about 80% of grafted cells 3 wk postgrafting. Dcx expression is reduced to 10%–
15% of HNu (þ) cells surrounding the grafting sites at 3 and 6 mo but remains very high (; 80%) in HNu (þ) cells on the contralateral gray matter up to 6
mo postgrafting.
(E) A confocal image of HNu (þ) (red) cells also labeled with Dcx (green) at 3 wk postgrafting.
(F) The three images illustrate, on a section that was dually stained for HNu (red nuclear marker on the left) and Ki67 (green nuclear marker in the center),
the very low rate of mitotic activity (double-stained nuclei on the right) in NSC grafts. The single double-stained nuclear profile is indicated with an arrow.
Scale bars: (A) 200 lm; (B) 600 lm; (E) 10 lm; (F) 20 lm.
doi:10.1371/journal.pmed.0040039.g002
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dispersed across the graft area without evidence of clustering
in speciﬁc sites.
A comparison among animals surviving for 3 wk, 3 mo, and
6 mo shows a tendency of NSCs to migrate away from the
initial grafting sites and populate both gray and white matter,
as well as the proximal end of ventral and dorsal roots in the
avulsion cases. Approximately 3% of NSC-derived cells were
found in the contralateral side. There were more cells in the
contralateral side in avulsion-injured than in HCA-injured
animals three months postgrafting (Figure 2C, far right
graph). The migratory disposition of NSCs was further
conﬁrmed with the expression of doublecortin (Dcx), a
microtubule-associated protein that serves as a speciﬁc
marker for migrating neuronal precursors [25], by about
80% of grafted cells three weeks postgrafting (Figure 2D and
2E). Dcx expression is reduced to 10%–15% of HNu (þ) cells
at the grafting sites at 3 and 6 mo but remains very high
(; 80%) in HNu (þ) cells on the contralateral side at 6 mo
postgrafting, evidence for continuous migration (Figure 2D).
In summary, human NSCs survive very well in the spinal
cords of nude rats with minimal further mitotic activity
irrespective of the presence or absence of lesions, and migrate
extensively into the ipsilateral and contralateral spinal cord.
Differentiation of Human NSCs into Neuronal and Non-
Neuronal Cells: Parenchyma versus Meninges, Gray versus
White Matter
Based on the aiming of the grafting pipettes, the main
portion of NSC grafts reviewed here was conﬁned within the
ventral horn of L4–L5 segments (Figure 2A). In this location,
the majority of grafted cells entered a neuronal lineage, as
evidenced by a   75% rate of TUJ1 immunoreactivity at 3 wk
and at 3 and 6 mo postgrafting (Figure 3A, 3B, and 3G). These
TUJ1 (þ) cells have round or bipolar cell bodies and an
average diameter of 10 lm (Figure 3A and 3B). Rates of TUJ1
differentiation did not differ signiﬁcantly among treatment
groups and were consistent with results from dual ICC for
HNu and the neuronal nuclear epitope NeuN. In addition,
there were no signiﬁcant differences in rates of TUJ1 (þ)
NSC-derived cells among various time points, evidence that
the establishment of a neuronal lineage occurs very early in
the life of these grafts. Compared to neuronal markers, the
appearance of astrocytic phenotypes was slower. HNu (þ) cells
do not show signiﬁcant GFAP immunoreactivity at 3 wk
postgrafting. By 3–6 mo, ; 5% of grafted HNu (þ) cells in the
avulsion cases and a slightly higher proportion of cells in
HCA ( ) and sham animals stained for GFAP (Figure 3G). The
astrocytic cytology of these GFAP (þ) cells is conﬁrmed by
confocal microscopy (Figure 3D). Nestin expression in
grafted cells declined over the time course studied here and
the greatest reduction was noted between 3 wk and 3 mo. A
percentage of 11%–14% of HNu (þ) cells remained nestin (þ)
even at 6 mo postgrafting (Figure 3G).
The fate of grafted human NSCs located in dorsal horn
exhibited similar patterns as in ventral horn. At 6 mo
postgrafting, rates of TUJ1 (þ) NSC-derived cells in dorsal
horn for avulsion, HCA, and sham groups were 71.1% 6
8.3%, 68.4% 6 13.6%, and 68.8% 6 4.3%, respectively
(Figure 3H, far left graph). Because of this similarity, fate
choices in ventral horn were taken as representative of the
entire spinal gray matter and were entered as such in all
subsequent comparisons with fate choices in the meninges
and white matter (see below).
In all animals examined, the pia adjacent to the inoculation
sites contained large numbers of grafted NSCs. At those sites,
differentiation pattern was different from parenchymal sites.
For example, the rates of GFAP (þ), astrocyte-like, NSC-
derived cells were 30%–50% in the various experimental
groups,andthereweremorecellspersistinginanestin(þ)state
(40%–53%) (Figure 3C, 3D, and 3G). At 6 mo, these rates were
higher than those in ventral horn in all experimental groups (p
,0.05) (Figure 3H, center andfar rightgraph). Insections that
were dually labeled for human nestin and GFAP, the two
phenotypes were expressed by distinct populations of NSC-
derivedcells, i.e.thevastmajority of GFAP(þ)cellswere nestin
( ) and nestin (þ) cells were GFAP ( ). Only 6%–11% of HNu
(þ)cellscolocalizedTUJ1immunoreactivityatpialsites(Figure
3G). These rates are signiﬁcantly lower compared to ventral
horn and white matter (p , 0.05) (Figure 3H, far left graph).
The neuronal differentiation of NSCs that were dispersed
in the ventral white matter, apparently by migration from the
ventral horn inoculation sites, was not as prominent as in
gray matter. At 6 mo postgrafting, percentages of dually
labeled cell for TUJ1 and HNu in ventral white matter are
59.6% 6 6.3%, 57.8% 6 3.0%, and 59.9% 6 4.5% for
avulsion, HCA, and sham treatments, respectively (Figure 3H,
far left graph). Differences in TUJ1 (þ) ratios between NSC-
derived cells located in ventral white matter and in ventral
horn are signiﬁcant within the same treatment group (p ,
0.05 for each one of the three groups). At the ventral white
matter, percentages of GFAP (þ) cells are 18.5% 6 5.6%,
20.0% 6 5.1%, and 16.1% 6 6.1% in the avulsion, HCA, and
sham groups; in the avulsion group, GFAP differentiation
rate is signiﬁcantly higher than in ventral horn (p , 0.05)
(Figure 3H, center graph). Nestin expression by HNu (þ) cells
is similar between ventral white matter and ventral horn
(Figure 3H, far right graph).
In both parenchymal and meningeal locations, we observed
infrequent HNu (þ) cells that also expressed A2B5, a
ganglioside antigen present in the common glial precursor
O-2A, at 3 mo as well as 6 mo postgrafting. In 6-mo grafts, a
population of smaller HNu (þ) cells in the ventral horn
expressed the mature oligodendrocyte marker adenomatus
polyposis coli (APC) in the ventral horn (8.8% 6 4.1%, 8.9%
6 3.0%, and 9.0% 6 1.8 % in avulsion, HCA, and sham
groups respectively), white matter (13.8% 6 2.6%, 12.2% 6
5.3%, and 12.0% 6 7.4%), and pia (6.4% 6 4.6%, 7.2% 6
3.3%, and 8.5% 6 1.9%). On confocal imaging, these cells
have a thin cytoplasm and multiple APC (þ) radial processes
consistent with oligodendrocytic cytology (Figure 3E and 3F).
In concert, the fate of grafted NSCs depends on location,
i.e., the parenchymal microenvironment overall promotes a
neuronal differentiation, and there is further inductive
inﬂuence in this direction in the gray matter. The meningeal
environment appears to facilitate astrocytic differentiation
or to induce NSCs to remain in a nestin (þ) state. In both
locations, about one-tenth of surviving NSCs differentiate in
the oligodendrocytic lineage. As proof of the concept that the
predominantly neuronal differentiation of NSCs is not
dependent on the athymic state of nude rats, we performed
a small study in which we grafted the lumbar cord of normal
rats. These animals were treated with FK506 to prevent
xenograft rejection. Two months postgrafting, animals were
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Neural Stem Cell Grafts in Spinal CordFigure 3. Differentiation of Grafted Human NSCs into Neurons and Glial Cells
Photomicrographs (A–F) illustrate cases of neuronal (A and B), astrocytic (C and D), and oligodendrocytic (E and F) differentiation of HNu (þ) cells by
epifluorescence (A, C, and E) or confocal (B, D, and F) microscopy. (G) is a composite of bar graphs illustrating the general differences in fate choice
between parenchymal (upper level) and meningeal (lower level) sites of NSC grafts. (H) provides further detail in differential fate choice among three
parenchymal sites and the pia compared side-by-side.
(A and B) These two sections are stained for HNu and TUJ1 and show the abundance of NSC-derived neurons within the parenchyma of the ventral horn
by epifluorescence (A) and confocal microscopy (B). Both preparations are taken from animals killed three months postgrafting. Inset is a magnification
of demarcated area in (A). Note the homogeneous appearance of TUJ1 (þ) cells in the A inset. Confocal sections have been virtually resectioned at the x
and y planes to confirm the identity of the double-stained structure.
(C and D) These sections, dually stained for HNu and GFAP, illustrate the substantial astrocytic differentiation of NSCs located by the pia membrane by
PLoS Medicine | www.plosmedicine.org February 2007 | Volume 4 | Issue 2 | e39 0325
Neural Stem Cell Grafts in Spinal Cordprepared exactly as the nude rats and the neuronal differ-
entiation of NSCs was explored with dual immunoﬂuores-
cence using NeuN and TUJ1 as neuronal markers. As in the
case of nude rats, the vast majority of NSCs had differentiated
into neuronal cells (Figure 4).
GABAergic and Cholinergic Neurotransmitter Phenotypes
Expressed by Grafted NSCs
Because of the predominant neuronal fate of grafted NSCs
excitatory, inhibitory (GABA) and cholinergic neurotransmit-
ter markers were examined in order to ascertain the degree of
differentiation of cells into the neuronal lineage (Figure 5).
Almost without exception, grafting sites were markedly
enriched in metabotropic glutamatergic (Figure 5A and 5B)
andGABAergic (Figure5C and 5D)neurotransmitter markers.
Individual bipolar NSC-derived cells were seen to express
strongimmunoreactivity forglutamate receptorsubunit2 and
3 (GluR2/3) and glutamate decarboxylase (GAD) and to be
contacted by terminals enriched in these two neurotransmit-
ter markers. Both GluR2/3 and GAD immunoreactivity ﬁrst
became apparent in grafting sites at 3 mo and persisted
without appreciable changes at 6 mo postgrafting.
Examination of sections stained for HNu, GAD, and GluR2/
3 showed a large number of NSC-derived neurons colocaliz-
ing both GAD and GluR2/3. To distinguish between GABAer-
gic and glutamatergic phenotypes in the nerve terminals, we
performed dual ICC for human-speciﬁc synaptophysin (Syn,
to mark graft-derived terminals) and GAD or vesicular
glutamate transporter type 1 and 2 (VGLUT1/2). GAD and
VGLUT1/2 are sensitive and selective markers for GABAergic
and glutamatergic neurons respectively [26,27], and terminal
staining is especially robust in the spinal cord (Figure 5E and
5G). To label a maximal number of glutamatergic terminals,
antibodies against VGLUT1 and VGLUT2 were used in
combination. Large numbers of GAD and VGLUT1/2 (þ)
terminals were seen at the grafting sites, but ﬁelds of
VGLUT1/2 (þ) puncta only partially overlapped the graft
(Figure 5G). In multiple ﬁelds in sections dually stained for
human-speciﬁc Syn and GAD, we found that a majority of Syn
(þ) terminals colocalized GAD immunoreactivity by confocal
microscopy (Figure 5F). In contrast, we observed no synaptic
colocalization of human Syn with VGLUT1/2 immunoreac-
tivity, despite dense apposition of individually labeled
terminals (Figure 5H).
Using GAD immunoreactivity as a marker of GABAergic
n e u r o n s ,w ec o u n t e dH N ua n dG A D( þ) proﬁles and
calculated rates of dually labeled cells in the total population
of HNu (þ) cells at 6 mo, i.e. the longest survival time
examined. At that time point, a signiﬁcant percentage of
HNu (þ) cells in all three experimental groups (avulsion:
60.5% 6 0.47%; HCA lesion: 56.4% 6 3.19%; sham: 49.57%
6 4.04%) were also GAD immunoreactive. Frequency of
differentiation did not vary signiﬁcantly by type of treatment.
A very small percentage of HNu (þ) cells (less than 1%), ﬁrst
appearing at 3 mo and consistently seen at 6 mo postgrafting,
colocalized choline acetyltransferase immunoreactivity. Chol-
ine acetyltransferase (þ) neurons were larger than other
neuronal HNu (þ) cells (15–25 lm in diameter) and displayed
multipolar cytologies (Figure 5I and 5J).
(Figure 3, continued) epifluorescence (C) and confocal microscopy (D). Inset is a magnification of demarcated area in (C), and representative astrocytes
are indicated with arrows. Confocal sections have been processed as in (B).
(E and F) Oligodendrocyte differentiation in ventral white matter based on APC immunoreactivity in the cytoplasm of cells with HNu (þ) nuclei as shown
with epifluorescence (E) and confocal microscopy (F). Blue nuclei represent DAPI counterstain. Arrow depicts a double-labeled cell. Arrowheads point to
host oligodendrocytes (APC [þ], HNu [ ] cells). Confocal sections have been processed as in (B).
(G) Bar graphs depicting the fate choices of NSC grafts in the parenchyma (including ventral and dorsal horn and ventral white matter, upper graphs) or
the meninges (lower graphs) at three weeks (3w), three months (3m), and six months (6m) in different treatment groups (avulsion, red; HCA treatment,
blue; sham, green). Neuronal fate is represented by numbers of TUJ1-labeled HNu (þ) cells, and astrocytic fate is represented by numbers of GFAP-
labeled HNu (þ) cells. NSCs in a neural stem/precursor state are depicted here as nestin-and HNu double-labeled cells. Asterisks indicate critical post hoc
differences between subgroups where ANOVA is significant (p   0.05).
(H) These graphs provide further detail into the role of spinal microenvironment in the fate choice of grafted NSCs by differentiating among three
parenchymal sites and the pia. Cell fates are represented by the same markers as in (G) Asterisks on top of brackets indicate important post hoc
differences where ANOVA is significant (p   0.05).
Scale bars: (A), (C), (E) 20 lm; (B), (D), (F) 10 lm.
doi:10.1371/journal.pmed.0040039.g003
Figure 4. DifferentiationofHumanNSCsintoNeuronsafterTransplantation
into the Lumbar Spinal Cord of Normal Adult Sprague-Dawley Rats
Outlined areas in (A) and (C) are enlarged in (B) and (D). All images
illustrate the neuronal differentiation of NSCs two months postgrafting
based on dual-label immunofluorescence for HNu (red) and a neuronal
marker (green, representing TUJ1 and NeuN in [A and B], and [C and D],
respectively). The predominance of double-labeled profiles in both (B)
and (D) (indicated with asterisks) matches the avid neuronal differ-
entiation of human NSCs in nude rats as illustrated in Figure 3. Single
HNu-labeled profiles (D) are shown with arrowheads
Scale bars: (A and B) 20 lm; (C and D) 10 lm.
doi:10.1371/journal.pmed.0040039.g004
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Neural Stem Cell Grafts in Spinal CordThese ﬁndings indicate that a majority of NSC-derived
neurons develop and sustain stable bipolar cytologies and
GABAergic phenotypes for at least six months after grafting.
These cells are contacted by GABAergic terminals from other
graft and host neurons and glutamatergic terminals from the
host. A small, but consistent, percentage of graft-derived
neurons evolve into larger multipolar neurons with
cholinergic phenotypes.
Evidence for Structural Integration of Human NSCs in Rat
Spinal Cord: Axons and Synapses
By 3 mo postgrafting, HNu (þ) neurons elaborate axons
(Figure 6A) and synapses (Figure 6B) that can be speciﬁcally
linked to graft origin with antibodies selective for human Syn
and neuroﬁlament proteins. Axons bundle in groups that
traverse across the white matter (Figure 6A). Axon projec-
tions into the ventral root were rare or inconsistent. To
evaluate the ability of HNu (þ) neurons to integrate within
the host circuitry, we labeled neural structures with graft- and
host-selective markers. For example, to separate host from
graft terminals, we used a monoclonal antibody for the
presynaptic protein Bsn that selectively recognizes rat and
mouse, but not human, epitopes. In sections stained for HNu
(to establish graft origin), TUJ1 (to establish neuronal
differentiation), and Bsn (to detect terminals from host rat
axons), we found that HNu (þ)a n dT U J 1( þ)c e l l si n
parenchymal locations were contacted by synaptic boutons
of rat origin (Figure 6C and 6D), i.e., evidence that the host
species (rat) innervates graft-derived (human) neuronal cells.
Because graft-derived terminals are negative for markers of
glutamatergic neurotransmission, VGLUT1/2 immunoreac-
tivity can be used to differentiate between graft and host
terminals. By combining ICC staining for HNu and TUJ1 (to
mark graft-derived neurons) with ICC staining for VGLUT1/2
(to label most host-derived glutamatergic terminals), we
found dense appositions between graft-derived neurons and
Figure 5. Neurotransmitter Differentiation of Grafted Human NSCs
Photomicrographs (A–J) illustrate evidence of glutamatergic (A and B, G
and H), GABAergic (C–F), and cholinergic (I and J) neurotransmission in
NSC grafts. As in previous figures, confocal microscopy is used primarily
to confirm the colocalization of two markers in the same cellular
compartment along three planes of sectioning.
(A and B) These sections, stained for HNu and the prevalent AMPA
receptor epitope GluR2/3, show both cytoplasmic and synaptic staining
by epifluorescence (A) or confocal (B) microscopy. Insets in (A) represent
magnifications of indicated neurons in main image; top- and bottom-left
insets show two medium-size HNu (þ) cells with cytoplasmic immunor-
eactivity, whereas bottom-right inset illustrates a larger HNu (þ) cell
containing multiple GluR2/3 (þ) boutons.
(C and D) These sections are stained for HNu and the GABA-synthesizing
enzyme GAD and visualized with epifluorescence (C) or confocal
microscopy (D). Arrows in (C) indicate multiple HNu (þ) cells with
cytoplasmic GAD immunoreactivity.
(E and F) Confocal microscopy of a field stained with both human Syn
(red in single-channel image on top left, to label graft-derived terminals)
and GAD (green in single-channel image on bottom left, to label
GABAergic terminals) shows colocalization of the two proteins (yellow
color in merged images in F) in multiple synaptic boutons. Nearly all
graft-derived boutons are inhibitory (F).
(G and H) These sections (G, epifluorescence; H, confocal) are stained for
human Syn to label graft-derived terminals (red) and mixed VGLUT1/
VGLUT2 antibodies to label glutamatergic terminals in the field (green).
Despite significant overlap and apposition of graft-derived and VGLUT1/
2( þ) terminals (G), the two groups of terminals are separate (H).
(I and J) These two sections were dually stained for: HNu and choline
acetyltransferase (I and insert) epifluorescence; confocal microscopy (J);
and show that some of the largest NSC-derived neurons express
cholinergic phenotypes. These cells elaborate multiple primary dendrites
(I and insert). (J) is the confocal image of the neuron in the inset.
Scale bars: (A), (C), (G), (I) 20 lm; (B), (D–F), (H), (J) 10 lm.
doi:10.1371/journal.pmed.0040039.g005
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Neural Stem Cell Grafts in Spinal Cordhost glutamatergic terminals (Figure 6E and 6F). In prepara-
tions stained for VGLUT1/2, GFAP, and HNu, we never
observed such contacts between host terminals and graft-
derived astrocytic proﬁles.
Conversely, preparations stained with human-speciﬁc Syn
and TUJ1 or choline acetyltransferase revealed dense terminal
ﬁelds of boutons apposed to host neurons, including large and
small motor neurons both on the side of grafting as well as the
contralateral side. Large numbers of host motor neurons were
seen to be contacted in such a fashion by graft-speciﬁc
terminals (Figure 7A and 7B). Treatment variance (avulsion,
HCA lesion, or sham treatment) did not seem to affect the
presence or absence of such dense contacts. In sections
stained for human Syn and GFAP, we did not observe any
appositions between graft-derived terminals and astrocytes.
In summary, NSC-derived neurons do not only develop
differentiatedneurotransmitterphenotypesintheadultspinal
cord, but also elaborate axons and synaptic specializations and
form synaptic contacts with host spinal cord neurons.
Discussion
Generalities
Our ﬁndings indicate a large-scale differentiation and
some structural integration of human NSCs grafted into the
normal and injured spinal cord of T cell deﬁcient (nude) rats.
Under the present experimental conditions, human NSCs
survive well with limited further mitotic activity and migrate
extensively for at least six months postgrafting. Although the
vast majority of NSCs in the spinal cord parenchyma take on
a neuronal fate, the meningeal environment is associated with
astrocytic phenotypes or the persistence of grafted NSCs in a
perpetual nestin (þ) state.
A majority of NSC-derived neurons in spinal cord
parenchyma have bipolar cytologies and GABAergic pheno-
types for at least six months after grafting and receive
GABAergic innervation from other graft and host neurons, in
addition to glutamatergic innervation from the host. A small
percentage of graft-derived neurons evolve into larger
multipolar neurons with cholinergic phenotypes. NSC-
derived neurons elaborate axons and synaptic specializations
and appear to engage in reciprocal innervation with host
spinal cord neurons. Importantly, when immunological
obstacles are overcome, rodent models are quite suitable
for the preclinical evaluation of human NSCs as tools for
repair of the injured spinal cord.
Survival and Migration
The 3- to 4-fold increase in NSC numbers postgrafting,
although not of the magnitude or rate to cause tumors,
persisted during the period of active neuronal differentiation.
Because it is implausible that the differentiation and dividing
pools of NSCs are the same cell population, we hypothesize
that the subset of grafted NSCs that persists in a nestin (þ)
state, for example NSC-derived cells located near the pial
surface, is the one that gives rise to additional neuronal
lineage, possibly on an ongoing basis. These cells may persist
in a stem cell state either because of accidental initial
placement near the pial environment or via active migration
and tropism to pial sites. These are complex phenomena that
require NSC-host signaling and require further investigation.
The migratory spread of human NSCs was especially
Figure 6. Maturation of Human NSC-Derived Neurons Based on the
Elaboration of Axons, Synapses, and Innervation by Host Neurons
(A) This photograph was taken through the ventral horn of a HNu/70 kDa
neurofilament protein stained section 3 mo postgrafting and shows
bundles of human 70 kDa neurofilament protein (þ) axons (indicated
with white arrows) originating in HNu (þ) grafts (one indicated with an
asterisk on top right) and coursing together (red arrows on bottom left)
toward the ventral white matter.
(B) This photograph shows an NSC graft in the ventral horn of a human
Syn-stained section three months postgrafting. The sharp colocalization
of Syn (þ) puncta with the graft region (boundaries demarcated with
arrows) is due to the selectivity of the antibody for human, but not rat,
Syn protein.
(C and D) These images (C, epifluorescence; D, confocal) were taken from
triple-stained sections with HNu (red), TUJ1 (blue), and the presynaptic
marker Bsn (green). The Bsn antibody used here recognizes rat and
mouse, but not human, protein. (C) depicts a dense field of rat Bsn (þ)
terminals in proximity to HNu and TUJ1 (þ) profiles. Examples of contacts
between rat terminals and NSC-derived neurons are shown with
arrowheads in the inset, which is a magnification of the profile at the
center of the main image. The very large number of such terminals on
NSC-derived cell bodies is best illustrated with confocal microscopy (D).
(E and F) These photographs (E, epifluorescence; F, confocal) were taken
from sections stained with HNu (red), TUJ1 (blue), and mixed VGLUT1/
VGLUT2 antibodies (green) and show the innervation of HNu and TUJ1
(þ) cells by glutamatergic terminals putatively originating in the host.
Scale bars: (A) 80 lm; (B) 20 lm; (C–F) 10 lm.
doi:10.1371/journal.pmed.0040039.g006
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Neural Stem Cell Grafts in Spinal Cordevident at three and six months, but a migratory disposition
was ascertained by Dcx immunoreactivity as early as three
weeks postgrafting. Although most HNu (þ) cells remained
within the gray matter, there was also colonization of the
white matter. A consistent phenomenon was the early
establishment of linear pathways of migration from the
initial graft into the white matter perpendicular to the spinal
cord surface, which often appeared to extend all the way to
the pia. In 49,6-diamidino-2-phenylindole-counterstained
preparations, it was apparent that these migratory pathways
were associated with microvessels. The generality of this
phenomenon invites further exploration of the role of
microvessels as guiding structures for NSC migration and of
the role of speciﬁc cells in the host vasculature as generators
of tropic and other signals for grafted NSCs.
Differentiation and Fate Choices
Neuronal differentiation of NSC grafts in the adult spinal
cord has been the exception, rather than the rule, in the
literature [6–9,11]. The relative success in the neuronal
differentiation of NSCs when these cells were grafted into
the developing spinal cord [28] is consistent with the idea that
essential inductive signals are present in the immature but
perhaps not the adult spinal cord [5,29]. The substantial
neuronal differentiation of embryonic stem cell/embryonic
body-derived NSCs in the adult spinal cord achieved by
McDonald and colleagues [10] was the ﬁrst indication that the
adult spinal cord environment may allow neuronal differ-
entiation under certain conditions. More promising results
were seen when human neuroteratocarcinoma cells or
committed neuronal precursors from rat spinal cord were
grafted in the ischemic spinal cord [12]. Survival of grafted
neurons in this report was very low, perhaps because of
immunological rejection, but graft-derived neurons assumed
GABAergic phenotypes and showed robust axonal growth.
The extensive neuronal differentiation of the NSC prepa-
ration used in the present study may be due to several reasons,
including species of NSC origin and culture method. For
example, human NSCs may have a greater pluripotentiality
compared to rodent NSCs [30]. Also, the fact that ; 5% of
human NSCs used here express PSA-NCAM prior to grafting
implies that a small portion of grafted cells had already made
a neuronal lineage choice. However, this preinoculation
choice of a small minority of grafted NSCs cannot account
for the massive neuronal differentiation of the graft that is
bound to have derived through multiple-step differentiation
postgrafting. Technical matters pertaining to the preparation
of cells, e.g., their propagation in monolayer cultures that
prevents a harsher treatment prior to their suspension for
grafting could also have played a role in the outcome.
The robust differentiation of NSCs in this study is
inconsistent with the general notion that the adult cord
environment is constitutively unfavorable to the survival and
differentiation of NSCs [5,29]. At the very least, our work
demonstrates that graft-intrinsic factors may be just as
important as the host microenvironment in determining
the in vivo differentiation of grafted NSCs. The T cell-
deﬁcient state of the experimental animals used here is
unlikely to have inﬂuenced the grafting outcome. In addition
to the successful grafting of human NSCs in nude rats, we
have achieved excellent survival and neuronal differentiation
of human NSC grafts in completely normal rats as well as in
SOD1-G93A transgenic rats and mice [31,32]. Cummings and
colleagues have recently published a report showing that a
quarter of human fetal brain-derived NSCs differentiate into
neurons in the contused spinal cords of NOD-scid mice [33].
In another study published while this paper was in review
[34], more than 50% of mouse NSCs grafted into the sindbis
virus-infected spinal cord differentiated into neurons, a large
percentage of which showed phenotypes and cytologies of
spinal motor neurons. Although there is substantial variety
among these models and only one other study used human
NSCs [33], the gist of this recent work is that neuronal
Figure 7. Innervation of Host Motor Neurons by Graft-Derived Nerve Cells as Shown on Sections Stained with Human Syn (Red) and TUJ1 (Green) and
Studied with Epifluorescence or Confocal Microscopy
Host motor neurons are depicted as large TUJ1 (þ) cell bodies, and NSC-derived terminals are labeled with human Syn antibodies.
(A) This epifluorescence image shows the site of the original graft (arrow in lower left) and two synaptic fields with host motor neuron pools marked as
(1) and (2), with respectively higher and lower density of synaptic appositions. The low-density field (2) is further enlarged in the inset.
(B) This confocal image shows, in great detail, a large number of somatic and dendritic terminals from graft-derived nerve cells on a host motor neuron.
Scale bars: (A) 200 lm; (B) 20 lm.
doi:10.1371/journal.pmed.0040039.g007
PLoS Medicine | www.plosmedicine.org February 2007 | Volume 4 | Issue 2 | e39 0329
Neural Stem Cell Grafts in Spinal Corddifferentiation of NSC grafts is certainly possible in the
mature spinal cord.
Our ﬁndings also show that local factors can inﬂuence the
fate choice of grafted NSCs, i.e., many more NSCs turn into
astrocytes or remain nestin (þ) when located close to the
meninges (pia). The gray matter may exert additional
inductive inﬂuences in the direction of neuronal differ-
entiation and certain lesions, i.e., root avulsions, appear to
facilitate an astrocytic fate choice. These patterns are
welcome evidence of NSC plasticity and suggest that signals
from the host microenvironment play signiﬁcant roles in the
differentiation choices of these cells in vivo. However, before
various preparations of cells are directly compared in the
same animal model, it is premature to draw generic
conclusions about differentiation trends of human NSCs in
the adult mammalian cord.
An unexpected ﬁnding in this paper was the measurable
differentiation of human NSCs into mature oligodendrocytes
six months after transplantation, especially given the low
preference of these cells for oligodendrocyte fate choice in
vitro. This is yet another indication of an important role of
the mature spinal cord environment in inducing relatively
immature precursors into diverse differentiation pathways.
Oligodendrocyte differentiation was the predominant fate of
a preparation of brain-derived human NSCs that was recently
grafted into the contused spinal cord of NOD-scid mice [33].
Neurotransmitter Identification and Axonal Growth
The predominant neurotransmitter phenotype of differ-
entiated NSCs is GABAergic, although a sizeable minority of
these cells acquires cholinergic phenotypes. It has been
reported that ‘‘priming’’ of human NSCs prior to grafting
may advance them more fully to cholinergic fates postgraft-
ing [35,36], but the likely advanced maturation state of these
cells pregrafting and unknown survival rates and grafting
efﬁciency does not allow direct comparisons with the results
of this study. GABAergic and cholinergic neurotransmitter
signatures appear to belong to neurons with different
cytologies, i.e., GABAergic neurons have smaller bipolar
cytologies whereas cholinergic neurons are larger and multi-
polar. However, all shapes and sizes between these two types
have been encountered and, in a few cases of grafts growing
outside the spinal cord parenchyma, we have seen a
continuous pattern of differentiation in colonies in which
GABAergic neurons predominate in the periphery and
cholinergic neurons at the center. Therefore, it is unlikely
that these two phenotypes belong at the end points of distinct
differentiation lineages and it is possible that some GABAer-
gic neurons could turn into cholinergic nerve cells given the
proper instructive signals. Another argument against the idea
of the GABAergic phenotype as an end-point fate is the fact
that a majority of HNu (þ) cells in the spinal cord extend long
axons, whereas GABAergic spinal cord neurons in mature
animals are interneurons [37,38].
A substantial degree of elongation of NSC-derived axons
was observed within the spinal cord parenchyma. This
observation suggests very little, if any, inhibitory effect from
the host in the elaboration and elongation of these axons.
The myelin-associated glycoprotein and the oligodendrocyte-
myelin glycoproteins NOGO A, B, and C have been shown to
inhibit axonal regeneration [39], although neurotrophic
factors can antagonize these effects by increasing intra-
cellular cAMP levels [40,41]. The lack of marked axonal
growth inhibition seen in our cases may be due to several
factors, one of which may be the minimally invasive nature of
the lesions employed here with little disruption of the blood–
brain barrier and absence of glial scarring. It has been
previously demonstrated that transplantation techniques that
minimize direct injury to spinal cord parenchyma lead to
successful axonal growth by limiting the adverse impact of the
reactive extracellular matrix at the lesion site and by
preventing cavitation and astrocyte transformation/migra-
tion [42,43]. Successful axonal regeneration without the use
of supplemental growth factors or manipulations of cAMP
levels has been reported from additional groups using grafts
of olfactory ensheathing [44] and developing human spinal
cord [45] cells in models of spinal cord injury.
Structural Integration of Graft with Host and Conclusions
The partial anatomical integration of grafted cells with host
neurons via the establishment of contacts observed here has
important theoretical and practical implications. Although
this is a novel phenomenon and the molecular mechanisms
are unknown, a number of trophic and cell–cell recognition
transcripts shown to be expressed by cultured human NSCs
are likely to play signiﬁcant roles in this process. These
protein signals are expressed and released in amounts and
gradients that allow highly conserved tropic and trophic
interactions to occur irrespective of age of the host, or the fact
that host and graft belong to different species. Based on our
PCR data on human NSCs in culture, these proteins include:
the prototypical glial-derived growth factor glial cell line-
derived neurotrophic factor and the neurotrophin BDNF, i.e.
potent trophic factors for motor neurons that can account for
the marked ability of human NSCs to attract host motor axons
[46–48]; the NRGs 1, 2, and 3, i.e., critical glial trophic signals
that may also guide host axons and promote host–graft
integration [49–55]; the growth hormone-like peptide IGF-1;
and angiogenic factors such as ﬁbroblast growth factor and
VEGF. Besides the neurotrophic effects of VEGF and IGF-1
[56–58], VEGF may also play a role in migration and position
patterning of developing motor neurons [59]. Interestingly,
IGF-1 may work in tandem with BDNF to promote neuronal
precursor differentiation [60], and this interaction may be
particularly relevant for the ﬁndings of this study.
In conclusion, NSCs from human spinal cord propagated in
vitro can be grafted successfully in the adult rat spinal cord
under a variety of experimental conditions and show marked
differentiation into projection neurons that appear to engage
in circuit formation with the host irrespective of species
differences. These outcomes indicate that, with successful
suppression of host immune rejection of the graft, rodent
models can be used for the preclinical evaluation of human
NSCs as cell support or replenishment tools to a much larger
extent than previously anticipated. It appears that cellular and
molecular factors that signal synaptic contact formation are
remarkablyconserved within themammalian class, despite the
fact that spatial and temporal patterning of developmental
events may differ among species. Together, our ﬁndings add
weighttotheargumentthatrestorationofspinalcordcircuitry
in traumatic and degenerative diseases may be a realistic goal
thatneedstobefurtherreﬁnedatthepreclinicalstagepriorto
its eventual consideration for clinical applications.
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Editors’ Summary
Background. Every year, spinal cord injuries, many caused by road traffic
accidents, paralyze about 11,000 people in the US. This paralysis occurs
because the spinal cord is the main communication highway between
the body and the brain. Information from the skin and other sensory
organs is transmitted to the brain along the spinal cord by bundles of
neurons, nervous system cells that transmit and receive messages. The
brain then sends information back down the spinal cord to control
movement, breathing, and other bodily functions. The bones of the
spine normally protect the spinal cord but, if these are broken or
dislocated, the spinal cord can be cut or compressed, which interrupts
the information flow. Damage near the top of the spinal cord can
paralyze the arms and legs (tetraplegia); damage lower down paralyzes
the legs only (paraplegia). Spinal cord injuries also cause many other
medical problems, including the loss of bowel and bladder control.
Although the deleterious effects of spinal cord injuries can be minimized
by quickly immobilizing the patient and using drugs to reduce
inflammation, the damaged nerve fibers never regrow. Consequently,
spinal cord injury is permanent.
Why Was This Study Done? Scientists are currently searching for ways
to reverse spinal cord damage. One potential approach is to replace the
damaged neurons using neural stem cells (NSCs). These cells, which can
be isolated from embryos and from some areas of the adult nervous
system, are able to develop into all the specialized cells types of the
nervous system. However, because most attempts to repair spinal cord
damage with NSC transplants have been unsuccessful, many scientists
believe that the environment of the spinal cord is unsuitable for nerve
regeneration. In this study, the researchers have investigated what
happens to NSCs derived from the spinal cord of a human fetus after
transplantation into the spinal cord of adult rats.
What Did the Researchers Do and Find? The researchers injected
human NSCs that they had grown in dishes into the spinal cord of intact
nude rats (animals that lack a functioning immune system and so do not
destroy human cells) and into nude rats whose spinal cord had been
damaged at the transplantation site. The survival and fate of the
transplanted cells was assessed by staining thin slices of spinal cord with
an antibody that binds to a human-specific protein and with antibodies
that recognize proteins specific to NSCs, neurons, or other nervous
system cells. The researchers report that the human cells survived well in
the adult spinal cord of the injured and normal rats and migrated into
the gray matter of the spinal cord (which contains neuronal cell bodies)
and into the white matter (which contains the long extensions of nerve
cells that carry nerve impulses). 75% and 60% of the human cells in the
gray and white matter, respectively, contained a neuron-specific protein
six months after transplantation but only 10% of those in the membrane
surrounding the spinal cord became neurons; the rest developed into
astrocytes (another nervous system cell type) or remained as stem cells.
Finally, many of the human-derived neurons made the neurotransmitter
GABA (one of the chemicals that transfers messages between neurons)
and made contacts with host spinal cord neurons.
What Do These Findings Mean? These findings suggest that human
NSC grafts can, after all, develop into neurons (predominantly GABA-
producing neurons) in normal and injured adult spinal cord and
integrate into the existing spinal cord if the conditions are right.
Although these animal experiments suggest that NSC transplants might
help people with spinal injuries, they have some important limitations.
For example, the spinal cord lesions used here are mild and unlike those
seen in human patients. This and the use of nude rats might have
reduced the scarring in the damaged spinal cord that is often a major
barrier to nerve regeneration. Furthermore, the researchers did not test
whether NSC transplants provide functional improvements after spinal
cord injury. However, since other researchers have also recently reported
that NSCs can grow and develop into neurons in injured adult spinal
cord, these new results further strengthen hopes it might eventually be
possible to use human NSCs to repair damaged spinal cords.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/doi:10.1371/journal.pmed.
0040039.
  The US National Institute of Neurological Disorders and Stroke
provides information on spinal cord injury and current spinal cord
research
  Spinal Research (a UK charity) offers information on spinal cord injury
and repair
  The US National Spinal Cord Injury Association Web site contains
factsheets on spinal cord injuries
  MedlinePlus encyclopedia has pages on spinal cord trauma and
interactive tutorials on spinal cord injury
  The International Society for Stem Cell Research offers information on
all sorts of stem cells including NSCs
  The US National Human Neural Stem Cell Resource provides
information on human NSCs, including the current US government’s
stance on stem cell research
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